The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -52,599 |
| Interest on debt instrument | 0 |
| Stock-based compensation | 19,163 |
| Prepaid expenses and other current assets | 4,827 |
| Accounts payable | 2,884 |
| Accrued liabilities | -421 |
| Net cash used in operating activities | -35,800 |
| Proceeds from issuance of common stock, warrants and pre-funded warrants, net of issuance costs | 23,216 |
| Proceeds from the exercise of warrants | 15,298 |
| Payments on short-term note | 0 |
| Net cash provided by financing activities | 38,514 |
| Net change in cash and cash equivalents | 2,714 |
| Cash and cash equivalents, beginning of period | 94,851 |
| Cash and cash equivalents, end of period | 97,565 |